Klotho Therapeutics Company
Focused on development and commercialization of recombinant human Klotho proteins to prevent and treat kidney disease and other diseases.
Founded Date:
2016
Last Funding Type:
Series A
Headquarters:
San Diego, California, United States
Investors Number:
1
Technology:
Geroscience
Employee Number:
1-10
Industry:
Biotechnology, Health Care
Estimated Revenue:
$1M to $10M
Last Funding Date:
2017
Funding Status:
Early Stage Venture
Investor Type:
Early Stage Venture
Total Funding:
10000000